High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
出版年份 2014 全文链接
标题
High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
作者
关键词
Biomarkers, Breast cancer, Clinical outcome, Epigenetics, HDAC2, Histone-modifying enzymes, LSD1, SIRT1
出版物
BMC CANCER
Volume 14, Issue 1, Pages -
出版商
Springer Nature
发表日期
2014-08-20
DOI
10.1186/1471-2407-14-604
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
- (2013) Berit Maria Müller et al. BMC CANCER
- The prognostic value of apoptotic and proliferative markers in breast cancer
- (2013) Charla C. Engels et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients
- (2013) Esther M. de Kruijf et al. BREAST CANCER RESEARCH AND TREATMENT
- Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells
- (2013) Shauna N. Vasilatos et al. CARCINOGENESIS
- Epigenetic inactivation of DNA repair in breast cancer
- (2012) Somaira Nowsheen et al. CANCER LETTERS
- Personalized Therapy in Breast Cancer
- (2012) Frederik Marmé et al. ONKOLOGIE
- Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells
- (2011) Yi Huang et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A SIRT1-LSD1 Corepressor Complex Regulates Notch Target Gene Expression and Development
- (2011) Peter Mulligan et al. MOLECULAR CELL
- COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients
- (2010) Johanna G. H. van Nes et al. BREAST CANCER RESEARCH AND TREATMENT
- Balance between SIRT1 and DBC1 expression is lost in breast cancer
- (2010) Ji-Youn Sung et al. CANCER SCIENCE
- The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1
- (2010) Yiwei Lin et al. EMBO JOURNAL
- Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma
- (2010) Ho Lee et al. HUMAN PATHOLOGY
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
- (2010) Shinya Hayami et al. INTERNATIONAL JOURNAL OF CANCER
- The Critical Role of the Class III Histone Deacetylase SIRT1 in Cancer
- (2009) T. Liu et al. CANCER RESEARCH
- Engagement of the Lysine-Specific Demethylase/HDAC1/CoREST/REST Complex by Herpes Simplex Virus 1
- (2009) H. Gu et al. JOURNAL OF VIROLOGY
- Deacetylation of cortactin by SIRT1 promotes cell migration
- (2008) Y Zhang et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started